Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
CRISPR Therapeutics
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Nurix Therapeutics, Inc.
Incyte Corporation
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Cancer Research UK
Turnstone Biologics, Corp.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Symphogen A/S
Molecular Templates, Inc.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Massachusetts General Hospital
Quadriga Biosciences, Inc.
Xencor, Inc.
Incyte Corporation
Augusta University
Incyte Corporation
Incyte Corporation
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Incyte Corporation
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)